A Rare Case of Systemic Reaction to Carrot Due to PR-10 in a Young Child

C Ferrigno1, C P Ratti2, I Scavone1

  • 1Allergy Unit-Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.

Insights

Pollen-Food Allergy Syndrome (PFAS) can rarely cause severe systemic reactions, not just mild oral symptoms. High IgE levels to Bet v 1 during pollen season may increase this risk.

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine
  • Molecular Diagnostics

Background:

  • Pollen-Food Allergy Syndrome (PFAS) commonly causes mild oral symptoms.
  • Pathogenesis-related proteins group 10 (PR-10) are linked to oral allergy syndrome due to their sensitivity to heat and digestion.
  • Systemic reactions in PFAS are rare but possible.

Purpose of the Study:

  • To report a case of anaphylaxis due to raw carrot consumption in a patient with birch pollen allergy.
  • To highlight potential risk factors for systemic reactions in PFAS.
  • To emphasize the importance of recognizing systemic PFAS manifestations.

Main Methods:

  • Case report of a 12-year-old boy with birch pollen allergy.
  • Clinical history of reactions to raw carrot and fennel.
  • Molecular diagnostics for specific IgE to PR-10 allergens.
  • Assessment of reaction during pollen season and tolerance to cooked carrot.

Main Results:

  • The patient experienced anaphylaxis after consuming raw carrot.
  • Molecular diagnostics confirmed isolated PR-10 sensitization (Bet v 1).
  • The reaction occurred during birch pollen season, and cooked carrot was tolerated.

Conclusions:

  • PFAS can present with severe systemic reactions, not exclusively mild oral symptoms.
  • High specific IgE for Bet v 1 and concurrent pollen season may be risk factors for systemic PFAS.
  • Clinicians should consider the potential for systemic reactions in pollen-cross-reactive allergies.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.0K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Defenses Against Pathogens and Herbivores02:26

Defenses Against Pathogens and Herbivores

Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
27.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K